Among the most discussed research compounds today are Tirzepatide and Retatrutide
As of mid-2023, a number of antibodies are being developed for the treatment of eosinophilic disorders, particularly EoE, including: Lirentelimab
You can scan a barcode, snap a photo, speak, search, or quick-add a repeat meal, then see how food lines up with weight, hunger, and symptoms
While treatment varies by severity, common approaches include: Dietary Modifications Small, frequent meals Low-fat, low-fiber diet Soft or liquid foods Avoid raw vegetables, fatty meats, and high-fiber grains Medications Prokinetics to improve stomach motility Anti-nausea medications Acid reduction therapies (if needed) Advanced Interventions Feeding tubes (severe cases) IV hydration Gastric electrical stimulation Surgery (rare) Important: Stopping the GLP-1 drug may improve symptoms but many patients continue to experience symptoms long-term
K.et al (2009)
Whilst transdermal patch delivery systems are being explored in research, it is crucial to understand that no GLP-1 patches are currently licensed or approved for use in the UK